Tilmann Lantzsch
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 6
- Co-authors
- Heinz Koelbl (10 shared papers)Lukas Hefler (6 shared papers)Christoph Grimm (5 shared papers)Alexander Reinthaller (3 shared papers)G. Sliutz (2 shared papers)Antje Lebrecht (4 shared papers)Eva Ulbrich (3 shared papers)J Buchmann (3 shared papers)
- Journals
- Breast Cancer Research and Treatment (3 papers)Breast Care (3 papers)Archives of Gynecology and Obstetrics (2 papers)The International Journal of Biological Markers (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Tilmann Lantzsch
23 papers receiving 803 citations
Peers
Comparison fields: 5 of 72
- Obstetrics and Gynecology 144
- Cancer Research 209
- Reproductive Medicine 93
- Oncology 294
- Immunology 119
Countries citing papers authored by Tilmann Lantzsch
This map shows the geographic impact of Tilmann Lantzsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Lantzsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Lantzsch more than expected).
Fields of papers citing papers by Tilmann Lantzsch
This network shows the impact of papers produced by Tilmann Lantzsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Lantzsch. The network helps show where Tilmann Lantzsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Tilmann Lantzsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 117 | |
| 2 | 2002 | 100 | |
| 3 | 2005 | 100 | |
| 4 | 2017 | 80 | |
| 5 | 2001 | 76 | |
| 6 | 2001 | 59 | |
| 7 | 2006 | 58 | |
| 8 | 2001 | 44 | |
| 9 | 2010 | 37 | |
| 10 | 2006 | 31 | |
| 11 | The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. | 2002 | 20 |
| 12 | 2004 | 15 | |
| 13 | 2004 | 15 | |
| 14 | 2021 | 13 | |
| 15 | 2007 | 10 | |
| 16 | 2016 | 10 | |
| 17 | 2013 | 10 | |
| 18 | 2013 | 8 | |
| 19 | 2019 | 7 | |
| 20 | 2022 | 3 |
About Tilmann Lantzsch
Tilmann Lantzsch is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Obstetrics and Gynecology, having authored 26 papers that have together received 819 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cell Adhesion Molecules Research (3 papers), Pelvic floor disorders treatments (2 papers), TGF-β signaling in diseases (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Obstetrics and Gynecology (144 citations), Cancer Research (209 citations), Reproductive Medicine (93 citations), Oncology (294 citations) and Immunology (119 citations). Tilmann Lantzsch has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Heinz Koelbl, Lukas Hefler, Christoph Grimm, Alexander Reinthaller, G. Sliutz, Antje Lebrecht, Eva Ulbrich, J Buchmann, Dieter Lampe and Elisabeth Ludwig. Their work appears in journals such as Breast Cancer Research and Treatment, Breast Care, Archives of Gynecology and Obstetrics, The International Journal of Biological Markers and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.